Alfred Zippelius

Prof. Alfred Zippelius, MD, is a full Professor of Translational Oncology at the Departments of Medical Oncology and Biomedicine, Cancer Immunology at the University Hospital Basel, Switzerland. In these functions, he is conducting clinical trials as well as supervises clinical research in his laboratory focusing on translational research in the area of cancer immunotherapy and the development of novel targeted cancer therapies.

Prof. Zippelius studied medicine at Ludwig-Maximilians-University (LMU) Munich, Germany, where he also performed experimental work for his MD thesis in the laboratory of world-renowned German Immunologist Prof. Dr. Gert Riethmüller. After this, he performed post-doctoral research work as a German Research Agency (DFG)/Emmy-Noether fellow at the Ludwig Institute for Cancer Research (LICR) in Lausanne, Switzerland, and thereafter became a principal investigator in the Tumor Immunology lab of the Medical Oncology Department at University Hospital Zurich, Switzerland. He was then appointed Swiss National Science Foundation (SNF) Professor and group leader of the Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel, where he subsequently became a full Professor of Translational Oncology. He has full responsibility for clinical trial design and applications and research in the Laboratory of Cancer Immunology.